by KeyaMedical | Apr 4, 2022 | Blog, Press
Seattle, WA– April 1, 2022– Keya Medical announced that DEEPVESSEL FFR (DVFFR), has been cleared by U.S. Food and Drug Administration (FDA).
by KeyaMedical | Jul 13, 2021 | All News, Press
Keya Medical showcased its deep learning-based diagnostic and treatment solutions at the World Artificial Intelligence Conference 2021 (WAIC 2021) held in Shanghai.
by KeyaMedical | Apr 19, 2021 | All News, Press
Keya Medical was recognized on the Top 100 Future Medical Companies List at the Fifth Future Healthcare VB100 Conference.
by KeyaMedical | Apr 13, 2021 | All News, Press
Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.
by KeyaMedical | Mar 9, 2021 | All News, Press
Keya Medical, a leading developer of medical AI technology, has received the Most Growth Enterprise Award granted by iiMedia Research, a third-party data mining and analysis company headquartered in China.
by KeyaMedical | Feb 25, 2021 | All News, Press
Keya Medical’s President of R&D, Dr. Kunlin Cao, has been recognized on the 2021 Forbes China Up-and-Coming Businesswomen list. The list highlights 20 accomplished women who have each played a significant role in shaping China’s business landscape.
Recent Comments